These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37261839)

  • 1. Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
    Zadnik K; Schulman E; Flitcroft I; Fogt JS; Blumenfeld LC; Fong TM; Lang E; Hemmati HD; Chandler SP;
    JAMA Ophthalmol; 2023 Oct; 141(10):990-999. PubMed ID: 37261839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
    Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
    JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 0.01% Atropine Eye Drops in Children With Myopia and Intermittent Exotropia: The AMIXT Randomized Clinical Trial.
    Wang Z; Li T; Zuo X; Zhang T; Liu L; Zhou C; Leng Z; Chen X; Wang L; Wang X; Liu H
    JAMA Ophthalmol; 2024 Aug; 142(8):722-730. PubMed ID: 38958962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
    Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
    BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
    Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
    JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Repeated Low-level Red Light on Myopia Prevention Among Children in China With Premyopia: A Randomized Clinical Trial.
    He X; Wang J; Zhu Z; Xiang K; Zhang X; Zhang B; Chen J; Yang J; Du L; Niu C; Leng M; Huang J; Liu K; Zou H; He M; Xu X
    JAMA Netw Open; 2023 Apr; 6(4):e239612. PubMed ID: 37099298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial.
    Wang W; Zhang F; Yu S; Ma N; Huang C; Wang M; Wei L; Zhang J; Fu A
    Eur J Pediatr; 2023 Jun; 182(6):2597-2606. PubMed ID: 36944782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial.
    Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
    J Pers Med; 2024 Feb; 14(2):. PubMed ID: 38392608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial.
    Chen Y; Xiong R; Chen X; Zhang J; Bulloch G; Lin X; Wu X; Li J
    Transl Vis Sci Technol; 2022 Oct; 11(10):33. PubMed ID: 36269184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
    Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Nakamura Y; Sotozono C; Oshika T; Morimoto T; Nishida K; Nishikawa N; Song YS; Tokutake T; Nishi Y; Shigeno Y; Kurihara T; Negishi K; Tsubota K; Ono M; Nakai T; Tan D; Tanaka S; Kinoshita S;
    Jpn J Ophthalmol; 2021 May; 65(3):315-325. PubMed ID: 33586090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Atropine for Childhood Myopia Control: The Atropine Treatment Long-Term Assessment Study.
    Li Y; Yip M; Ning Y; Chung J; Toh A; Leow C; Liu N; Ting D; Schmetterer L; Saw SM; Jonas JB; Chia A; Ang M
    JAMA Ophthalmol; 2024 Jan; 142(1):15-23. PubMed ID: 38019503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
    Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
    Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
    Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopia progression after cessation of low-dose atropine eyedrops treatment: A two-year randomized, double-masked, placebo-controlled, cross-over trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Gan J; Bai W; Tian J; Cai Z; Yin L; Wang N
    Acta Ophthalmol; 2023 Mar; 101(2):e177-e184. PubMed ID: 35999653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.